As Newlyme Electronic Services and Trade Joint Stock Company;
Pursuant to articles 7 and 8 of the Regulation on Commercial Communication and Commercial Electronic Messages, we are obliged to obtain your approval in order to send commercial electronic messages.
In addition, Article 5 of the Law on the Protection of Personal Data No. 6698 and the Personal Data Protection Board, primarily dated 08/07/2019 and numbered 2019/04, dated 31/05/2019 and numbered 2019/159, dated 31/05/2019 It is not possible for us to send you commercial electronic messages without your express consent, including the decisions numbered 2019/162.
We must notify you of innovations and developments via e-mail, and since it is within the scope of commercial e-mail, we must fulfill our obligations written above for sending e-mails.
For these reasons, we request your explicit consent on whether the e-mail address information you have shared can be used to send you commercial electronic messages.
We would like to emphasize that; Commercial electronic messages will not be sent without your express consent under any circumstances. The decision on this matter is entirely at your discretion and we do not force you to do so.
We remind you to take your explicit consent decision in line with the Doctor Disclosure Text before, and we want you to know that your choice will not cause any negativity in your relationship with us. When you feel such a negativity, you can inform us at [email protected].
Confirming this checkbox will mean that your contact data will be processed for the purpose of sending you commercial electronic messages. If the box is not ticked, it will be deemed that you do not have your explicit consent and your contact data will not be processed for the purpose of sending commercial electronic messages, therefore an e-mail in the form of a commercial electronic message will not be sent to you.